<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002020'>Gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) is a <z:hpo ids='HP_0011010'>chronic</z:hpo> disorder that affects millions of people worldwide and has the potential to lead to serious consequences, including <z:e sem="disease" ids="C0546837,C0152018" disease_type="Neoplastic Process" abbrv="">cancer of the esophagus</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It for this reason that there is such intense interest in the topic, this emphasized by the identification of some 341 articles published in the English language in the year 2000 alone </plain></SENT>
<SENT sid="2" pm="."><plain>The present report highlights the results of a number of studies that either increase our understanding of the condition or raise important issues about its diagnosis and treatment </plain></SENT>
<SENT sid="3" pm="."><plain>Included in the areas covered are (1) the role of genetics in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>; (2) the mechanism for transient lower esophageal sphincter relaxations and their association with <z:hpo ids='HP_0002036'>hiatal hernias</z:hpo>; (3) the role of Helicobacter pylori in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo>; (4) efficacy and safety of <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>; and (5) the mechanism for <z:hpo ids='HP_0011010'>chronic</z:hpo> cough in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, among others </plain></SENT>
</text></document>